Chein‐Soo Hong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Chein‐Soo Hong has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Byungjoo Park
Korean Association of Regional Pharmacovigilance Centers, Yonsei University College of Medicine, Seoul, Korea
1 shared publicationEung‐Gyu Kim
Korean Association of Regional Pharmacovigilance Centers, Yonsei University College of Medicine, Seoul, Korea
1 shared publication- Jung-Won Park
Division of Allergy and Immunology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
1 shared publication Sung‐Kyu Choi
Korean Association of Regional Pharmacovigilance Centers, Yonsei University College of Medicine, Seoul, Korea
1 shared publication- Yong Won Lee
Division of Allergy & Clinical Immunology, Department of Internal Medicine, Center for Health Policy Research, Catholic Kwandong University College of Medicine, International St. Mary’s Hospital, Incheon, Korea
1 shared publication Yoo Seob Shin
Korean Association of Regional Pharmacovigilance Centers, Yonsei University College of Medicine, Seoul, Korea
1 shared publication
Latest Publications
- 20 July 2009
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 18 (10) , 910-915
Spontaneous reporting of adverse drug events by Korean regional pharmacovigilance centers
Purpose Patterns of prescriptions are markedly influenced by regional disease entities, medical education, culture, economic status, and available pharmaceutical companies. Features of adverse drug reactions (ADRs) may vary in different countries. In this study, we analyzed the causative drugs and clinical manifestations of spontaneously reported ADRs in Korea. Methods Six Korean Regional Pharmacovigilance Centers collected 1418 cases of spontaneously reported adverse drug events (ADEs) by doctors, pharmacists, and nurses, and the clinical features and causative drugs were evaluated. The data were collected from general hospitals (76.5%), primary clinics, and pharmacies (23.5%). Results Based upon the World Health Organization (WHO)‐Uppsala Monitoring Center criteria (certain—13.7%, probable—46.1%, possible—32.1%), 91.9% of the collected events were suspected to be ADRs and 15.8% of patients experienced serious ADRs. The most prevalent causative drugs were antibiotics (31.6%), followed by contrast dyes (14.0%), non‐steroidal anti‐inflammatory drugs (NSAIDs) (11.1%), anti‐psychotics (5.4%), anti‐convulsants (5.2%), cardiovascular agents (4.8%), anti‐neoplastics (4.6%), and opiates and non‐opiate pain killers (3.5%). Among the antibiotics, cephalosporins (8.1%) were the most common, followed by anti‐tuberculosis agents (5.7%), quinolones (4.0%), vancomycin (3.1%), and penicillin (2.8%). The most common side effect was skin manifestations, which were seen in 42% of the patients, followed by neurologic manifestations (14%), gastrointestinal involvements (12.9%), generalized reactions (9.4%), and respiratory involvements (4.5%). Conclusion Antibiotics, contrast dyes, and NSAIDs were the most common causative drugs for ADRs, which reflects the prescription pattern and the prevalence of diseases in Korea. These data may be useful in establishing a Korean pharmacovigilance system. Copyright © 2009 John Wiley & Sons, Ltd.
- 20 July 2009
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 18 (10) , 910-915
Spontaneous reporting of adverse drug events by Korean regional pharmacovigilance centers
Purpose Patterns of prescriptions are markedly influenced by regional disease entities, medical education, culture, economic status, and available pharmaceutical companies. Features of adverse drug reactions (ADRs) may vary in different countries. In this study, we analyzed the causative drugs and clinical manifestations of spontaneously reported ADRs in Korea. Methods Six Korean Regional Pharmacovigilance Centers collected 1418 cases of spontaneously reported adverse drug events (ADEs) by doctors, pharmacists, and nurses, and the clinical features and causative drugs were evaluated. The data were collected from general hospitals (76.5%), primary clinics, and pharmacies (23.5%). Results Based upon the World Health Organization (WHO)‐Uppsala Monitoring Center criteria (certain—13.7%, probable—46.1%, possible—32.1%), 91.9% of the collected events were suspected to be ADRs and 15.8% of patients experienced serious ADRs. The most prevalent causative drugs were antibiotics (31.6%), followed by contrast dyes (14.0%), non‐steroidal anti‐inflammatory drugs (NSAIDs) (11.1%), anti‐psychotics (5.4%), anti‐convulsants (5.2%), cardiovascular agents (4.8%), anti‐neoplastics (4.6%), and opiates and non‐opiate pain killers (3.5%). Among the antibiotics, cephalosporins (8.1%) were the most common, followed by anti‐tuberculosis agents (5.7%), quinolones (4.0%), vancomycin (3.1%), and penicillin (2.8%). The most common side effect was skin manifestations, which were seen in 42% of the patients, followed by neurologic manifestations (14%), gastrointestinal involvements (12.9%), generalized reactions (9.4%), and respiratory involvements (4.5%). Conclusion Antibiotics, contrast dyes, and NSAIDs were the most common causative drugs for ADRs, which reflects the prescription pattern and the prevalence of diseases in Korea. These data may be useful in establishing a Korean pharmacovigilance system. Copyright © 2009 John Wiley & Sons, Ltd.